Resources

The latest in biomarkers research, from development and diagnostics to precision medicine

Biomarkers for Drug Discovery & Development

Abcam: Cancer Biomarkers Guide

Biomarkers for Drug Discovery & Development

Merck: Analyte Quarterly

Biomarkers for Drug Discovery & Development

SomaScan Assay Services

Biomarkers for Drug Discovery & Development

Complex biologies, intelligently simplified.

Biomarkers for Drug Discovery & Development

Merck: Complete Biomarker Solutions

Biomarkers for Drug Discovery & Development

Multiplex Immunoassays for Idiopathic Pulmonary Fibrosis

Biomarkers for Drug Discovery & Development

SomaScan Panels

Biomarkers for Drug Discovery & Development

Almac Diagnostic Services

Biomarkers for Drug Discovery & Development

Introducing SomaScan® 11K Assay

Biomarkers for Drug Discovery & Development

2024 SomaLogic UK Research Grant Award

Biomarkers for Drug Discovery & Development

SomaSignal® Tests

Biomarkers for Drug Discovery & Development

Merck: Expanding Possibilities in Animal Health

Biomarkers for Drug Discovery & Development

Merck MILLIPLEX® Multiplex Assay User Guide

Biomarkers for Drug Discovery & Development

Nu.Q Nets: Monitoring the immune system to save lives

Biomarkers for Drug Discovery & Development

Almac: Biomarkers for Biotech

Biomarkers for Drug Discovery & Development

Abcam: Antibodies that keep you moving forward

Biomarkers for Drug Discovery & Development

Diagnexia Clinical Trials Pathology Services

Biomarkers for Drug Discovery & Development

Abcam: Progress happens together

Biomarkers for Drug Discovery & Development

Biomarker Discovery and the Identification of the First Cancer Biomarker

In modern healthcare, biomarkers are an integral part of approaches to monitoring patient health and condition, providing researchers with a means of predicting treatment response. But what was the first biomarker to be discovered?
Biomarkers for Drug Discovery & Development

High-Throughput Biomarker Discovery for Clinical Trial Optimization

On-Demand Webinar featuring Dr Mo Jain, Founder & CEO of Sapient

This webinar shares how next-generation, high throughput mass spectrometry, advanced data analysis, and population-scale data are being leveraged for robust discovery of biomarkers that can be used to align patients, disease biology, and therapeutic interventions for clinical trials.
Biomarkers for Drug Discovery & Development

Selection Biomarkers: Shaping the Future of Drug Development and Regulatory Approval

While constraints on the integration of NGS approaches in selection biomarker validation for new treatments still need ironing out, their benefits in assisting clinical trial progress are undeniable.
Biomarkers for Drug Discovery & Development

The Potential Uses of AI in Biomarker Discovery and Biomarker Validation

With efforts already being made to apply artificial intelligence to imaging data for improved biomarker validation, AI is here to stay. However, to truly streamline drug development it needs to be implemented practically.
Biomarkers for Drug Discovery & Development

Bioassay Optimisation: How the Pandemic Reshaped International Standards for New Therapeutics

The global race to develop, trial, and distribute a vaccine for Covid-19 may have permanently accelerated the development of future therapeutics, including treatments for cancer.
Biomarkers for Drug Discovery & Development

New Therapeutic Target for Aggressive Breast Cancer

Scientists at VCU Massey Cancer Center pinpoint druggable target in aggressive breast cancer.
Biomarkers for Drug Discovery & Development

Indivumed Biobank

Biomarkers for Drug Discovery & Development

Treating the Untreatable: Unlocking Precision Medicine Biomarkers for NASH

Introducing PreciNASH, a multidisciplinary consortium strengthening the link between research outputs and clinical applications in NASH disease treatment.
Biomarkers for Drug Discovery & Development

What’s Next for Predictive Biomarkers in Immunotherapy?

From maximising immune response with combination biomarkers to conducting diagnostic innovation in immunotherapy prognosis, the future of predictive biomarkers is fast approaching. We speak to senior representatives from industry and academia to find out more.
Biomarkers for Drug Discovery & Development

Developing a biomarker? Keep these 3 takeaways in mind

Three key take aways when you develop biomarkers: one during biomarker discovery, one during biomarker development and one during biomarker validation.
Biomarkers for Drug Discovery & Development

The 5 most common pitfalls when developing biomarkers

Discovering a strong biomarker is an expensive and time-consuming process. One of the key takeaways is to take your time and look at the data before you start testing for biomarkers.
Biomarkers for Drug Discovery & Development

The future of biomarkers: where are they heading?

Biomarkers come in many shapes and sizes. It’s an ever-evolving subject with many under-discovered possibilities. Let’s look at some ways biomarkers are looking to evolve.
Biomarkers for Drug Discovery & Development

Indivumed Biobank

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biomarkers